ClinicalTrialsFinder

For Acute or Chronic Infections Between July 2019 and December 2024 Clinical Trials in France, Lyon

1 recruitingFrance, Lyon, France

Showing 1–1 of 1 trials

Recruiting

Efficacy and Safety of Dalbavancin As Suppressive Therapy

Efficacy and Safety of DalbavancinIn Subjects Who Received SAT with DALFor Acute or Chronic Infections Between July 2019 and December 2024
Hospices Civils de Lyon33 enrolled1 locationNCT06899906